Overview of KDRA, KHIDI. & Korean Pharmaceutical Industry
|
|
|
- Domenic Sharp
- 7 years ago
- Views:
Transcription
1 Overview of KDRA, KHIDI & Korean Pharmaceutical Industry
2
3 Member companies KDRA member companies, regular and associate, are all leading and representing the R&D based pharmaceutical & biotech industries of Korea and have been conducting almost all of research and development activities in the field of Korean pharmaceutical & biotech industry. These companies are investing more considerable R&D expenditure than any other companies existing in the industry and occupying over 60% of the domestic market. KDRA member companies have been involving in pioneering unmet medical needs areas investing over 65% to their annual net profit with the strong support from the Korean government, continuous pursuit of R&D productivity & efficiency to overcome the disadvantageous R&D resources in comparision with the advanced nations, highly educated & experienced R&D manpower, strong passion for new drug development, strategic & dynamic nationwide collaboration network between the industry, academia and public research orgs. and strong will & vision for global market. Regular Members Ahn-gook Pharm ILYANG Pharm. Whanin Pharm DreamPharma Corp. Institut Pasteur Korea BCWORLD PHARM JW Pharmaceutical YUHAN Corporation Hanall Biopharma Inc. Reyon Pharm Co. Ltd. Bukwang Pharm. Kolon Life Science. Inc. Yuyu Pharma Inc. Hanlim Pharm. Sam Chun Dang Pharm. Chemizon Inc. Korea United Pharm. Inc. Thomson Reuters HUONS Samyang Corporation CJ Cheiljedang Corp. KUKJE Pharma. Ind. Amore PACIFIC ILDONG Pharmaceutical SK biopharmaceuticals Daewoong Pharmaceutical KYONGBO Pharmaceutical BORYUNG Pharmaceutical CO., Ltd JEIL Pharmaceutical ViroMed Dong-A Pharmaceutical Myungmoon Pharm. Celltrion Chemical Research Institute Kolmar Korea YD life science company Dong Wha Pharm. Ind. Korea Otsuka Pharmaceutical Chong Kun Dang Pharmaceutical Corp. Korean Drug Yung Jin Pharm. Green Cross Corp. RNL BIO Croen Research Incorporated KPX LIFE SCIENCE Korea Institute of Toxicology Handok Pharmaceutical. Samjin Pharm Deawon Pharm. Co., Ltd Kwang-dong Pharmaceutical Hanmi Pham Co Ltd. Shin Poong Pharmaceutical Dong Kook Pharmaceutical LG Life Sciences Ltd.Yung Jin Pharm. Hyundai Pharm. Ind. SK Chemicals
4
5
6
7
8
9
10 R&D New Drug Approval Status of Major Korean Pharmaceutical Companies by Therapeutic Category Source : KDRA Survey over 37 Leading Pharmaceutical companies in 2012 New Drug R&D Pipelines of Major Korean Pharmaceutical Companies by Active Ingredient Source : KDRA Survey over 37 Leading Pharmaceutical companies in 2012 New Drug R&D Pipelines of Major Korean Pharmaceutical Companies by R&D Stage Source : KDRA Survey over 37 Leading Pharmaceutical companies in 2012 New Drug R&D Pipelines of Major Korean Pharmaceutical Companies by Therapeutic Category Source : KDRA Survey over 37 Leading Pharmaceutical companies in 2012 New drug R&D ecosystem of Korean Pharmaceutical Industry
11 R&D Investment R&D Investment to Sales Revenue of Major Korean Pharmaceutical Companies Source : KDRA Survey over 37 Leading Pharmaceutical companies in 2012 R&D Investment Plan( ) of 44 Innovative Korean Pharmaceutical Companies Source : KHIDI Survey over 44 Innovative Korean Pharmaceutical companies in 2012 Korean Regulatory & Healthcare Syetem R&D Investment to Net Profit of Major Korean Pharmaceutical Companies Source : KDRA Survey over Leading Pharmaceutical companies in 2010
12
Dear Business Development or Corporate Alliance Director/Manager,
Korea Drug Research Association(KDRA) and Korea Health Industry Development Institute(KHIDI) cordially request the potential global outsourcing partners(cros, CMOs, CSOs & Consulting Firms) having contract
Outlook of China Biopharmaceutical Outsourcing Market
中 国 生 物 医 药 外 包 市 场 前 景 分 析 Outlook of China Biopharmaceutical Outsourcing Market JZMed, Inc. Report Description Attracted by the fast growth of the Chinese biopharmaceutical market as well as the thriving
Drug Re-Examination/Data Exclusivity in JAPAN and Neighboring Countries
Japan Pharmaceutical Manufacturers & Association Drug Re-Examination/Data Exclusivity in JAPAN and Neighboring Countries AIPPI Forum & ExCo Workshop Pharma IV September 6, 2013 at Helsinki Yoichi OKUMURA
Healthcare. abc. Healthcare team
team Nam Park* Regional Head of Research, Asia Pacific The Hongkong and Shanghai Banking Corporation Limited +852 2996 6591 nampark@hsbc.com.hk Carolyn Poon* Analyst The Hongkong and Shanghai Banking Corporation
Achievement of Korea s Healthcare Industry. Devices. World s largest market share in ultrasound imaging devices ( 14) Competitiveness
2015 Healthcare Healthcare Korea's healthcare industry is growing thanks to the advancement of the production infrastructure of pharmaceuticals, medical devices and cosmetics, support for healthcare-related
An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore
An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight on Bangalore A CanBiotech Report CanBiotech, 2007 1 An Overview of the Life Sciences and Outsourcing Landscape in India: Spotlight
NEW CHEMICAL ENTITIES
NEW CHEMICAL ENTITIES PIONEERING PARTNER FOR PEPTIDES With more than 40 years of expertise in peptide synthesis, a track record in process development, large-scale manufacturing and outstanding product
STATS WINDOW. INDUSTRY REVIEW AT A GLANCE Global Pharmaceutical Industry
Volume 6, Issue 6, December 2013 STATS WINDOW The Pacific Business Review International has taken an initiative to start a section which will provide a snapshot of major Global & Indian economic indicators
The majority of pharmaceutical companies in
Pharmaceutical Infrastructure and Industry Professor Che-Ming Teng, Ph.D. National Taiwan University College of Medicine, Taipei, Taiwan The majority of pharmaceutical companies in Taiwan are devoted to
An integrated global healthcare company
An integrated global healthcare company 1 A Mission to create healthier communities globally Zydus Cadila is dedicated to life In all its dimensions. Our world is shaped by a passion for innovation, commitment
Spring 2013. From Our CEO. Special Event WuXi Forum - Gateway to China Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai
From Our CEO Special Event WuXi Forum - Gateway to China Chinese Premier Li Keqiang Visits WuXi Headquarter in Shanghai Featured Story WuXi and PRA Form Joint Venture to Offer Clinical Research Services
TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet
TransCelerate's Role in Transforming Pharmaceutical Trials Presentation to PCORNet Dalvir Gill, PhD - Chief Executive Officer 17 October, 2014 Presentation Objectives + TransCelerate History + Participating
2015 CMR INTERNATIONAL PHARMACEUTICAL R&D EXECUTIVE SUMMARY
2015 CMR INTERNATIONAL PHARMACEUTICAL R&D EXECUTIVE SUMMARY AUGUST 2015 2 CMR FACTBOOK 2015 EXECUTIVE SUMMARY INTRODUCTION R&D productivity across the global biopharmaceutical industry is a well-documented
Rx-360 An International Pharmaceutical Supply Chain Consortium
Rx-360 An International Pharmaceutical Supply Chain Consortium Overview Rx-360 and the Audit Sharing Program September 2011 Rx-360 Members (Continuously updated list at www.rx-360.org) Manufacturers (24)
Tuas Biomedical Park
Tuas Biomedical Park About Tuas Biomedical Park Tuas Biomedical Park symbolises JTC s commitment in developing a world-class manufacturing hub for the biomedical industry. The park is located in Tuas View,
Coming of age: genericscentred players flourishing, preparing to go global. Korean biopharmaceuticals. Buy Celltrion, Korea s biosimilar leader
ANCHOR REPORT Korean biopharmaceuticals EQUITY RESEARCH Buy Celltrion, Korea s biosimilar leader Coming of age: genericscentred players flourishing, preparing to go global Backed by a supportive domestic
APAC CRO Market A deep dive into the trends transforming APAC CRO industry. P86A-52 June 2015
APAC CRO Market A deep dive into the trends transforming APAC CRO industry June 2015 Table of Contents Section Slide Numbers Executive Summary 10 Key Findings 11 Total CRO Market Size By Stages of Clinical
Transforming relationships Unleashing innovation
Transforming relationships Unleashing innovation Translating Discoveries Into Products A model for innovation driven economic growth Barbara Handelin, PhD 1 The Innovation Gap Economic Opportunity Industries
Profile of Biomedical Research and Biotechnology Commercialization. San Diego Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization San Diego Metropolitan Statistical Area Overview and History of Biotechnology in San Diego San Diego has a significant concentration of
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry PROJECT MANAGEMENT: RENOVATION OF RESEARCH LABORATORY FOR CELL CULTURE
Introduction. The Healthcare Sector in Asia - Current Situation. Projected Healthcare Expenditure
Policy Issues in the Economics and Financing of Medical Technology in the Asia-Pacific Region Dr KAI HONG PHUA Joint Professor Yong Loo Lin School of Medicine and Lee Kuan Yew School of Public Policy National
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry CLEANING VALIDATION Instructors Loh Kean Chong Rick Ng Date and Time
Investment summit supports Australian biotech industry to attract investment and grow
Investment summit supports Australian biotech industry to attract investment and grow During 2014, more than $500 million in investment was raised for Australian biotech. A Scientific American survey of
Organizational Capital, R&D Assets, and Outsourcing
Organizational Capital, R&D Assets, and Outsourcing Wendy Li 2013 Federal Committee on Statistical Methodology Research Conference Bureau of Economic Analysis November 5, 2013 Motivation and Challenge
PharmD Postdoctoral Fellowship Program
Novartis Institutes for Biomedical Research and Massachusetts College of Pharmacy and Health Sciences, Worcester/Manchester PharmD Postdoctoral Fellowship Program Introduction Fellowship training in the
Salary Survey 2014. Domestic, International Salary Survey and Country Cost Analysis
Salary Survey 2014 Domestic, International Salary Survey and Country Cost Analysis Disclaimer: This salary guides contained herewith have been constructed to represent average salaries across a range of
WHO PREQUALIFICATION IN NIGERIA PHARMA INDUSTRY PERSPECTIVE CHIEF OLUBUNMI OLAOPA OCTOBER 30, 2013
WHO PREQUALIFICATION IN NIGERIA PHARMA INDUSTRY PERSPECTIVE CHIEF OLUBUNMI OLAOPA OCTOBER 30, 2013 OUTLINE NIGERIAN PHARMA SECTOR PRINCIPLE OF WHO PREQUALIFICATION PRODUCTS OF INTEREST FOR WHO PQP PROCESS
Powering Cutting Edge Research in Life Sciences with High Performance Computing
A Point of View Powering Cutting Edge Research in Life Sciences with High Performance Computing High performance computing (HPC) is the foundation of pioneering research in life sciences. HPC plays a vital
Rutgers Mini-MBA : BioPharma Innovation
Rutgers Mini-MBA : BioPharma Innovation Ga i n t h e s k i l l s to t r a n s f o r m scientific i n n ovat i o n i n to business success www.cmd.rutgers.edu/innovation Rutgers Mini-MBA : BioPharma Innovation
2015 / 2016 Awards Criteria and Submission Information
9 th Annual ViE Awards 2015 / 2016 Awards Criteria and Submission Information In association with: Dear colleague, The Vaccine Industry Excellence (ViE) Awards have been created to honor and generate recognition
Is a Career in the. Pharmaceutical. Check out our online Student Center to find out more: www.aaps.org/forstudents
Is a Career in the Pharmaceutical Sciences Right for Me? Check out our online Student Center to find out more: www.aaps.org/forstudents How Do I Know If a Career in the Pharmaceutical Sciences is Right
Healthcare Innovation in the UK - A Royal Society of Chemistry Position Paper
Healthcare Innovation in the UK - A Royal Society of Chemistry Position Paper Introduction The pharmaceutical industry (Pharma) has made important contributions to quality of life, longevity, economic
Santaravalley: Integrating scientific research, high-tech business and academia Prof. Vladas Algirdas Bumelis President of Santara valley Association Vilnius, Lithuania 2013July 18 th Santara Valley Association
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality
6 th Proactive GCP Compliance Effective Risk- Based Approaches for Optimizing Clinical Quality March 24-25, 2015 Wyndham Philadelphia Historic District, Philadelphia, PA www.exlevents.com/gcp Sponsors
Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum
Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities
Installation of Power Supply Monitoring System for Digital Computer Controllers(DCC)
Installation of Power Supply Monitoring System for Digital Computer Controllers(DCC) 2011.04.12 KOREA HYDRO& NUCLEAR POWER CO., LTD Nam-hwan, Seul Voltage Monitoring Alarm Service Maintenance ETC
Profile of Biomedical Research and Biotechnology Commercialization. Washington-Baltimore Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization Washington-Baltimore Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Washington-Baltimore The Washington,
THOMSON REUTERS CORTELLIS FOR INFORMATICS. REUTERS/ Aly Song
THOMSON REUTERS CORTELLIS FOR INFORMATICS REUTERS/ Aly Song THOMSON REUTERS CORTELLIS FOR INFORMATICS 1 Table of Contents Table of Contents...1 The challenge... 2 The solution... 2 WHAT CAN YOU DO WITH
State of the Life Sciences Mergers and Acquisitions Market
State of the Life Sciences Mergers and Acquisitions Market Brian Miller, Managing Partner and Co-Founder, Linden Partners Rich Fante, RF Consulting LLC, Formerly with AstraZeneca Americas Mark Nicholson,
Location for Trials- Global Considerations A Pharma Perspective. Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014
Location for Trials- Global Considerations A Pharma Perspective Carlo Maccarrone Assoc. Director, Clinical Research GSK Australia 7 May 2014 Why Choose Australia for Clinical Trials? What is he saying
RNL BIO CO., LTD. (KOSPI CODE : 003190) Investor Relations 2007
RNL BIO CO., LTD. (KOSPI CODE : 003190) Investor Relations 2007 Jeong Chan Ra President and CEO Safe Harbor This presentation may contain forward looking statements including projections and business trends.
Analysis of the Relationship between Corporate IT Capability and Corporate Performance through Korea IT Success Cases: An Empirical Approach
Asia Pacific Journal of Information Systems Vol. 20, No. 3, September 2010 1) Analysis of the Relationship between Corporate IT Capability and Corporate Performance through Korea IT Success Cases: An Empirical
In-depth analysis of the report is based on propriety databases, primary and secondary research and inhouse analysis by a team of experts.
Brochure More information from http://www.researchandmarkets.com/reports/1882193/ Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising
VTT Technical Research Centre of Finland 2010
VTT Technical Research Centre of Finland 2010 02/04/2010 2 GDP share of R&D expenditure in Finland % 3 3.43 3.45 3.48 3.45 3.47 3.72 3.92 2.1 1990 1998 2003 2004 2005 2006 2007 2008 2009 Source: Statistics
WHITE PAPER. Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations
WHITE PAPER Developing Biosimilars in Emerging Markets: Regulatory and Clinical Considerations ppdi.com March 2013 EXECUTIVE SUMMARY Emerging markets in Asia Pacific, Latin America and Eastern Europe are
The list of Korean registered fishery processing establishments export products to China
The list of Korean registered fishery processing establishments export products to China 1 KP-002 WOOIL FISHERIES Co. 450-20, Wonsu-ri, Janghang-eup, Seochun-gun, Chungnam Fishery products 2 KP-005 YOUNG
Toward Acceleration of Open Innovation
Toward Acceleration of Open Innovation ーThe Role of Industrial-Academic- Government-Collaborationー Masafumi Nogimori Representative Director and Chairman Astellas Pharm Inc. International Symposium New
Emerging Clinical Sites: India and China. Patrycja Doba, Clinical Research Coordinator
Emerging Clinical Sites: India and China Patrycja Doba, Clinical Research Coordinator Overview 1. Outsourcing trends in Pharmaceutical Industry 2. Reasons for outsourcing 3. The most outsourced activity
Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020
Brochure More information from http://www.researchandmarkets.com/reports/3291836/ Global Market Study on E-clinical Solution Software: Asia to Witness Highest Growth by 2020 Description: E-clinical solution
Association of Power Exchange 17-19 October 2010 Smart Grid in Korea (Jeju smart grid pilot project) Hwang, Bong Hwan
Association of Power Exchange 17-19 October 2010 Smart Grid in Korea (Jeju smart grid pilot project) Hwang, Bong Hwan Korean Power Exchange Smart Grid Roadmap 2 수색 Current Situation Overview of Korea Korea
Future roles and opportunities for statisticians in pharmaceutical industry
Future roles and opportunities for statisticians in pharmaceutical industry H. Ulrich Burger 1), Stefan Driessen 2), Chrissie Fletcher 3), Michael Branson 4), Christoph Gerlinger 5) 1) Hoffmann-La Roche
Profitability and Consistency Analysis of Pharmacy Sector in India
Profitability and Consistency Analysis of Pharmacy Sector in India Dr. K.S. Vataliya Principal M.J College of Commerce Maharaja Krishanakumarsinhji Bhavnagar University, Bhavnagar, India Rajesh A. Jadav
Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM 2015. Alliance. Innovation PRELIMINARY. Management
OCTOBER 5-6, 2015 PARIS, FRANCE 6 th EDITION THE LEADING PARTNERING MEETING IN OPEN INNOVATION FOR LIFE SCIENCES CONFERENCES EXHIBITION HALL ONE-ON-ONE PARTNERING MEETINGS NETWORKING Open PRELIMINARY PROGRAM
Our passion is to deliver sustainable value to our customers 2007 First Half Results 26 July 2007
Our passion is to deliver sustainable value to our customers 2007 First Half Results 26 July 2007 Toralf Haag Chief Financial Officer Disclaimer Certain matters discussed in this presentation may constitute
New Mid-Term Business Plan Sunrise 2012
New Mid-Term Business Plan Sunrise 2012 CHUGAI PHARMACEUTICAL CO.,LTD. President and CEO Osamu Nagayama January 30/31, 2008 Forward Looking Statements This presentation may include forward looking statements
BioPharma Analytics Informing every move
Specialty Solutions Insight Decisions Providers Payors Direction Patients BioPharma Analytics Informing every move Achieve market success faster with evidence-based market intelligence Cardinal Health
Biopharmaceutical Portfolio Management Optimization under Uncertainty
Ian David Lockhart Bogle and Michael Fairweather (Editors), Proceedings of the 22nd European Symposium on Computer Aided Process Engineering, 17-20 June 2012, London. 2012 Elsevier B.V. All rights reserved
Brochure More information from http://www.researchandmarkets.com/reports/3292678/
Brochure More information from http://www.researchandmarkets.com/reports/3292678/ Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long
Post-Doctoral Pharmaceutical Industry Fellowship. A Two-Year Clinical Development Program
Post-Doctoral Pharmaceutical Industry Fellowship A Two-Year Clinical Development Program Today, we innovate by creating new medicines, as well as new methods of drug discovery and delivery. We strive to
Profile of Biomedical Research and Biotechnology Commercialization. Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area
Profile of Biomedical Research and Biotechnology Commercialization Boston-Worcester-Lawrence Consolidated Metropolitan Statistical Area Overview and History of Biotechnology in Boston Along with San Francisco,
HINJ and New Jersey s Life Sciences Community
HINJ and New Jersey s Life Sciences Community Since 1997, the HealthCare Institute of New Jersey (HINJ) has ser ved as the leading voice of the state s life sciences industr y. HINJ seeks to expand patient
NOTICE OF 2010 AND PROXY STATEMENT
NOTICE OF 2010 ANNUAL MEETING AND PROXY STATEMENT REXAHN PHARMACEUTICALS, INC. TO OUR SHAREHOLDERS: NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To be held June 14, 2010 Notice is hereby given that the Annual
West Nile Virus Infections-Pipeline Insights, 2016
Brochure More information from http://www.researchandmarkets.com/reports/3533615/ West Nile Virus Infections-Pipeline Insights, 2016 Description: West Nile Virus Infections-Pipeline Insights, 2016 provides
Acucela Inc. IR Meeting
Acucela Inc. IR Meeting Tokyo May 20, 2015 Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening
Chronic Plaque Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
Brochure More information from http://www.researchandmarkets.com/reports/3533727/ Chronic Plaque Psoriasis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016 Description: SUMMARY The
Accelerating Drug & Clinical Trial Approvals in China & East Asia
25 28 March 2014 The Westin Beijing Chaoyang, Accelerating Drug & Clinical Trial Approvals in & East Asia What s New in 2014? Key Regulatory Update from the National Institute for Food & Drug Control,
Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements
Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements Pharmaceutical Sciences Applied sciences that underlie the practice of pharmacy the development, manufacture,
Background: Pathways for the Master s Degree (Thesis and Non Thesis)
Differences between the Non Thesis (Project) and Thesis Options for the M.S. in Pharmacy with an emphasis in BioPharma Regulatory Affairs Offered by the University of Georgia College of Pharmacy Background:
GMP Pharma BV. Netherlands
GMP Pharma BV Netherlands Connecting the European & Indian Pharmaceutical, Biotechnology and Biopharmaceutical Industry for parallel growth and solicitation. About Us: GMP Pharma BV is a multisource organization
2014 Taiwan Delegation Company Participants
2014 Taiwan Delegation Company Participants (BIO International Convention Exhibitors) PharmaEssentia Address: 13F, No. 3, Park Street, NanKang District, Taipei 115, Taiwan (Nangang Software Park) Website:
Drug Regulations in India Dr. Surinder Singh Drugs Controller General (India) Meeting With Ambassadors / High Commissioners of African Countries 24
Drug Regulations in India Dr. Surinder Singh Drugs Controller General (India) Meeting With Ambassadors / High Commissioners of African Countries 24 th April 2009, New Delhi Flow of presentation About Indian
SPHERIX INCORPORATED (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event
UNLEASHING THE NEXT GENERATION OF BIOTECHNOLOGY INNOVATION
UNLEASHING THE NEXT GENERATION OF BIOTECHNOLOGY INNOVATION Modern biotechnology is a young industry. But in just over four decades, the scientists, researchers and entrepreneurs working in this field have
Building innovative drug discovery alliances. Profitable. Growth Go
Building innovative drug discovery alliances Innovation n & Profitable Growth Go Evotec AG, H1 Presentation, 8 th August 2012 Forward-looking statements Information set forth in this presentation contains
Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies
Biosimilar Monoclonal Antibodies in the Pipeline: Major Players and Strategies Fern Barkalow, Ph.D, Senior Analyst, Oncology Citeline One of the biggest challenges facing biosimilar drug developers is
CMC Sourcing in Transition: Consolidation, Offshoring and the Market Outlook. Pharmaceutical Technology Breakfast at AAPS November 7, 2005
CMC Sourcing in Transition: Consolidation, Offshoring and the Market Outlook Pharmaceutical Technology Breakfast at AAPS Market conditions CRO/CMO posted strong results in H1 2005 H1 2005 Revenue Growth
Product Life Cycle Management in Life Sciences Industry
Life Cycle Management in Life Sciences Industry Evolving from siloed to cross-functional management Audit. Tax. Consulting. Corporate Finance. A need for Lifecycle Management Life Sciences companies are
A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute
A Texas Life Science Perspective Thomas R. Kowalski President Texas Healthcare and Bioscience Institute 1 What is THBI? The Texas Healthcare and Bioscience Institute (THBI) is a non-profit, public policy
A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market
A Product and Pipeline Analysis of the Multiple Sclerosis Therapeutics Market Launch of Several Pipeline Oral Products Could Diminish the Market for Injectable Therapies NEC3-52 November 2014 Contents
The Management of Pharmaceuticals in the Environment (PIE) FAQ. Key questions and answers. Q: How do pharmaceuticals get into the environment?
The Management of Pharmaceuticals in the Environment (PIE) FAQ Key questions and answers Q: How do pharmaceuticals get into the environment? A: Like many foods and supplements that are consumed by humans
Clinical Trial Trends Outline Complexity for Supply Chain. Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.
Clinical Trial Trends Outline Complexity for Supply Chain Scott Ohanesian, VP Commercial Operations APAC Email: Scott.Ohanesian@marken.com 29 May 2013 Biotechnology Sales on the Rise Source: EvaluatePharma
Global Opioid Dependence Drugs Market Highlights - 2015
Brochure More information from http://www.researchandmarkets.com/reports/3293542/ Global Opioid Dependence Drugs Market Highlights - 2015 Description: The latest research Global Opioid Dependence Drugs
Introduction to Enteris BioPharma
Introduction to Enteris BioPharma Enteris BioPharma Intelligent Solutions for Oral Drug Delivery Privately held, New Jersey based biotech company Owned solely by Victory Park Capital, a large Chicago based
Delcin Consulting Group
Delcin Consulting Group 1375 Locust Street, Suite 200, Walnut Creek, CA 94596 Phone: 925-276-2095 Fax: 925-276-2096 Email: info@delcinconsulting.com Website: www.delcinconsulting.com All Rights Reserved,
Medicines for Neglected Diseases Workshop. Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia
Medicines for Neglected Diseases Workshop Dennis Liotta, Ph.D. Director Emory Institute for Drug Discovery Atlanta, Georgia September 11, 2010 Poverty, Many People Poor health conditions High Morbidity
OFFICE OF INTERNATIONAL BUSINESS DEVELOPMENT PENNSYLVANIA S INNOVATION ECOSYSTEMS AND OPPORTUNITIES FOR CLUSTER COOPERATION
OFFICE OF INTERNATIONAL BUSINESS DEVELOPMENT PENNSYLVANIA S INNOVATION ECOSYSTEMS AND OPPORTUNITIES FOR CLUSTER COOPERATION Where is Pennsylvania? PA is located within 500 miles of: 40% of the U.S. population
Cegedim Half-year results 2009 September 2009
Cegedim Half-year results 2009 September 2009 1 Cegedim : Healthcare - its primary market Cegedim Founded in 1969 by Jean-Claude Labrune Jean-Claude Labrune family hold 67 % of Cegedim through FCB 849
Global Contract Research Organization (CRO) Industry: Overview and Trends, 2008
A Service of Indigo Research A Cipher www.indigoresearch.com Global CRO Market 2005- $15 Billion Global Contract Research Organization (CRO) Industry: Overview and Trends, 2008 Published April 2008 CRO
Competitive Advantages for Pharma Investing in Belgium
Competitive Advantages for Pharma Investing in Belgium Creating Value in the Heart of Europe Thursday 21 November 2013 Location: CIPAL Cipalstraat, 2440 Geel A visit of the Genzyme Geel plant will be organised
- 12 - Korean won (In thousands) 2007 2006 Available-for-sale:
12 5. SHORTTERM AND LONGTERM INVESTMENT SECURITIES: (1) Shortterm investment securities consist of beneficiary certificates and various bonds of 503,388,199 thousand and 221,788,518 thousand as of December
BioBusiness Biopharmaceutical Ingredients Recombinant albumins & albumin fusion Dermot Pearson, Strategic Product Director, NZ Biopharma
BioBusiness Biopharmaceutical Ingredients Recombinant albumins & albumin fusion Dermot Pearson, Strategic Product Director, NZ Biopharma 2 Novozymes solutions dedicated to the biopharmaceutical industry
Medicines Benefits in Korea
Medicines Benefits in Korea International Expert Meeting on Medicines as a Key Component of Universal Health Coverage Singapore - Oct 2, 2013 Soonman KWON, Ph.D. Dean School of Public Health Seoul National
The Innovative Pharmaceutical Manufacturing Industry: Driving Economic Growth
The Innovative Pharmaceutical Manufacturing Industry: Driving Economic Growth March 2015 About the Author Nam D. Pham is Managing Partner of ndp analytics, a strategic research firm that specializes in
Review Article INTEGRATION OF PROJECT-PRODUCT LIFECYCLE IN PHARMACEUTICAL INDUSTRY
International Journal of Research and Development in Pharmacy and Life Sciences Available online at http//www.ijrdpl.com October - November, 2013, Vol. 2, No.6, pp 631-635 ISSN: 2278-0238 Review Article
Pharmaceutical sales in Canada have a 2.5 percent share of the global market, making th
Industry Canada (/eic/site/icgc.nsf/eng/home) Home Industries and Business Canadian Life Science Industries Biopharmaceuticals and pharmaceuticals Pharmaceutical industry profile Life Science Industries
The Board reviews risks to the Company s business plan at its scheduled meetings.
Pharmaxis Ltd 1. Board responsibility The Pharmaxis Board is responsible for ensuring the Company establishes and maintains a risk management framework for the oversight and management of risk. The Board
Job description. Job title. Process Engineer. Responsible to. Process Engineering Manager. Hours/sessions per week 37.
Job description Job title Directorate Pay band Responsible to Base/location Process Engineer Production SEO Process Engineering Manager Porton Hours/sessions per week 37.5 Job type Permanent INTRODUCTION
Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing
Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Thursday 08 October 2015 8-9 October 2015, Copenhagen (Denmark) Medicon Valley Alliance,
Pr. Dominique JOLLY SKEMA BS. Animatrice : Valérie BLANCHOT COURTOIS
Cycle Innovation & Connaissance 17 petit déjeuner Vendredi 14 février 2014 Comment les entreprises occidentales parient sur la création technologique en Chine? Du cost-driven au knowledge-driven Pr. Dominique
BioWorld s PARTNER in FOCUS: Covance AN ADVERTISING SERVICE FROM BIOWORLD
BioWorld s PARTNER in FOCUS: Covance AN ADVERTISING SERVICE FROM BIOWORLD PARTNERING Trend Allows Smart CROs TO Provide Gamut of Services TO Any Size COMPANy Five years ago, contract research organizations